You are viewing the site in preview mode
Skip to main content
|
Group
|
Total (n = 472)
|
Con (n = 317)
|
NAFLD (n = 155)
|
P
|
|---|
|
Age (Year)
|
44 ± 13
|
43 ± 14
|
47 ± 11##
|
< 0.001
|
|
Sex (Male/Female)
|
224/248
|
139/178
|
85/70
|
0.992
|
|
BMI (kg/m2)
|
25.93 ± 4.05
|
24.45 ± 3.25
|
28.97 ± 3.83##
|
< 0.001
|
|
SBP (mmHg)
|
127 ± 15
|
124 ± 15
|
133 ± 14##
|
< 0.001
|
|
DBP (mmHg)
|
78 ± 10
|
77 ± 9
|
83 ± 10##
|
< 0.001
|
|
WC (cm)
|
87.9 ± 11.9
|
83.9 ± 10.9
|
96.1 ± 9.4##
|
< 0.001
|
|
FBG (mmol/L)
|
5.41 (5.07,5.87)
|
5.29 (4.97,5.61)
|
5.78 (5.38,6.46) ##
|
< 0.001
|
|
FINS (mmol/L)
|
10.65 (7.35,15.24)
|
8.89 (6.43,11.84)
|
16.15 (11.19,19.90) ##
|
< 0.001
|
|
HOMA-IR
|
2.60 (1.70,3.82)
|
2.09 (1.47,2.95)
|
4.12 (3.01,5.71) ##
|
< 0.001
|
|
TC (mmol/L)
|
4.72 ± 1.01
|
4.59 ± 0.96
|
5.00 ± 1.06##
|
< 0.001
|
|
TG (mmol/L)
|
1.66 ± 1.31
|
1.34 ± 1.07
|
2.32 ± 1.50##
|
< 0.001
|
|
HDL-C(mmol/L)
|
1.25 ± 0.28
|
1.30 ± 0.29
|
1.14 ± 0.22##
|
< 0.001
|
|
LDL-C(mmol/L)
|
2.98 ± 0.73
|
2.85 ± 0.69
|
3.23 ± 0.74##
|
< 0.001
|
|
ApoA1(g/L)
|
1.40 (1.24,1.56)
|
1.42 (1.27,1.60)
|
1.34 (1.20,1.51) #
|
=0.001
|
|
ApoB(g/L)
|
0.79 ± 0.22
|
0.75 ± 0.20
|
0.88 ± 0.23##
|
< 0.001
|
|
ApoA1/ApoB
|
1.78 (1.48,2.22)
|
1.94 (1.61,2.36)
|
1.57 (1.28,1.86) ##
|
< 0.001
|
- Data are mean ± standard deviation or median (interquartile range)
- Abbreviations: BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, FBG fasting blood glucose, FINS fasting plasma insulin concentration, HOMA-IR homeostasis model assessment of insulin resistance, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein-cholesterol, LDL-C low-density lipoprotein-cholesterol, ApoA1 apolipoprotein A1, ApoB apolipoprotein B
- # P < 0.05, compared with the Con group. ##P < 0.01, compared with the Con group
